West Pharmaceutical Services | WST - Current Assets


West Pharmaceutical Services reported $1.83B in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Align Technology USD 2.66B 38.87M Mar/2026
Avanos Medical USD 325M 30.4M Mar/2026
Baxter International USD 6.85B 25M Mar/2026
Becton, Dickinson and Co. USD 8.01B 1.18B Mar/2026
Cerus USD 174.38M 7.26M Dec/2025
Charles River Laboratories USD 1.49B 41.76M Mar/2026
Cooper Companies USD 2.13B 27.4M Dec/2025
Dentsply International USD 1.85B 178M Mar/2026
Haemonetics USD 834.88M 108.8M Mar/2026
ICU Medical USD 1.21B 22.69M Mar/2026
Insulet USD 1.71B 204.5M Mar/2026
Integra LifeSciences USD 1.17B 12.47M Mar/2026
IQVIA Holdings USD 6.22B 29M Mar/2026
J&J USD 59.17B 3.55B Mar/2026
Medtronic USD 24.07B 75M Dec/2025
Merit Medical Systems USD 1.1B 61.62M Mar/2026
Neogen USD 590M 15.42M Dec/2025
OraSure Technologies USD 240.78M 21.13M Mar/2026
Quidel USD 1.38B 70.3M Mar/2026
Repligen USD 1.16B 23.98M Mar/2026
Rockwell Medical USD 31.61M 1.42M Jun/2025
Solventum Corp USD 3.58B 276M Mar/2026
STAAR Surgical USD 312.4M 853K Mar/2026
Terumo JPY 861.04B 45.48B Mar/2026
Utah Medical Products USD 97.74M 1.21M Dec/2025
West Pharmaceutical Services USD 1.83B 151.4M Mar/2026